Relation of β-Blocker Use With Frequency of Hospitalization for Heart Failure in Patients With Left Ventricular Diastolic Dysfunction (from the Heart and Soul Study)

被引:15
作者
Smith, Dustin T. [2 ]
Farzaneh-Far, Ramin [1 ]
Ali, Sadia [3 ]
Na, Beeya [3 ]
Whooley, Mary A. [1 ,3 ]
Schiller, Nelson B. [1 ]
机构
[1] Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA 94143 USA
[2] Vet Affairs Med Ctr, Atlanta, GA 30033 USA
[3] Vet Affairs Med Ctr, San Francisco, CA 94121 USA
关键词
MYOCARDIAL-INFARCTION; EJECTION FRACTION; TASK-FORCE; CARVEDILOL; HYPERTENSION; MORBIDITY; PROGNOSIS; MORTALITY; COMMITTEE; SYMPTOMS;
D O I
10.1016/j.amjcard.2009.08.677
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heart failure (HF) is a common public health problem, and many new cases are now recognized to occur in patients with preserved left ventricular ejection fraction. beta Blockers improve the outcomes of patients with known left ventricular systolic dysfunction, but whether beta blockers provide similar protection among patients with left ventricular diastolic dysfunction is unclear. We studied the association between use of beta blockers and subsequent hospitalization for HF in patients with diastolic dysfunction and stable coronary heart disease. We evaluated medication use and performed echocardiography at baseline in a prospective cohort of 911 outpatients with known coronary heart disease from the Heart and Soul Study. Hospitalizations for HF were assessed by blinded review of the medical records during an average follow-up of 5.2 years. Of the 911 participants, 118 (13%) had diastolic dysfunction, of whom 2 were lost to follow-up. Of the 116 remaining patients, 19 (25%) of the 77 using beta blockers were hospitalized for HF compared to 16 (41%) of the 39 not using beta blockers (age-adjusted hazard ratio 0.51, 95% confidence interval 0.26 to 1.00; p = 0.05). This association remained after additional adjustment for gender, smoking, history of myocardial infarction, diabetes, and creatinine (hazard ratio 0.46, 95% confidence interval 0.23 to 0.93; p = 0.03). The results were similar after excluding 31 participants with a history of self-reported HF (hazard ratio 0.33, 95% confidence interval 0.13 to 0.86; p = 0.02) and 24 participants with concurrent systolic dysfunction (hazard ratio 0.36, 95% confidence interval 0.14 to 0.89; p = 0.03). In conclusion, the use of beta blockers is associated with a decreased risk of hospitalization for HF in patients with diastolic dysfunction and stable coronary heart disease. Published by Elsevier Inc. (Am J Cardiol 2010;105:223-228)
引用
收藏
页码:223 / 228
页数:6
相关论文
共 30 条
[1]   Effects of digoxin on morbidity and mortality in diastolic heart failure: The ancillary Digitalis Investigation Group trial [J].
Ahmed, Ali ;
Rich, Michael W. ;
Fleg, Jerome L. ;
Zile, Michael R. ;
Young, James B. ;
Kitzman, Dalane W. ;
Love, Thomas E. ;
Aronow, Wilbert S. ;
Adams, Kirkwood F., Jr. ;
Gheorghiade, Mihai .
CIRCULATION, 2006, 114 (05) :397-403
[2]   ACC/AHA 2007 Guidelines for the Management of Patients With unstable Angina/Non-ST-Elevation Myocardial Infarction A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine [J].
Anderson, Jeffrey L. ;
Adams, Cynthia D. ;
Antman, Elliott M. ;
Bridges, Charles R. ;
Califf, Robert M. ;
Casey, Donald E., Jr. ;
Chavey, William E. ;
Fesmire, Francis M. ;
Hochman, Judith S. ;
Levin, Thomas N. ;
Lincoff, A. Michael ;
Peterson, Eric D. ;
Theroux, Pierre ;
Wenger, Nanette Kass ;
Wright, R. Scott ;
Smith, Sidney C. ;
Jacobs, Alice K. ;
Halperin, Jonathan L. ;
Hunt, Sharon A. ;
Krumholz, Harlan M. ;
Kushner, Frederick G. ;
Lytle, Bruce W. ;
Nishimura, Rick ;
Ornato, Joseph P. ;
Page, Richard L. ;
Riegel, Barbara .
CIRCULATION, 2007, 116 (07) :E148-E304
[3]   Changes in early and late diastolic filling patterns induced by long-term adrenergic beta-blockade in patients with idiopathic dilated cardiomyopathy [J].
Andersson, B ;
Caidahl, K ;
diLenarda, A ;
Warren, SE ;
Goss, F ;
Waldenstrom, A ;
Persson, S ;
Wallentin, I ;
Hjalmarson, A ;
Waagstein, F .
CIRCULATION, 1996, 94 (04) :673-682
[4]   2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction - A report of the American college of cardiology/American heart association task force on practice guidelines [J].
Antman, Elliott M. ;
Hand, Mary ;
Armstrong, Paul W. ;
Bates, Eric R. ;
Green, Lee A. ;
Halasyamani, Lakshmi K. ;
Hochman, Judith S. ;
Krumholz, Harlan M. ;
Lamas, Gervasio A. ;
Mullany, Charles J. ;
Pearle, David L. ;
Sloan, Michael A. ;
Smith, Sidney C., Jr. .
CIRCULATION, 2008, 117 (02) :296-329
[5]  
Antman Elliott M., 2004, J Am Coll Cardiol, V44, pE1, DOI 10.1016/j.jacc.2004.07.014
[6]   Effect of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction >=40% treated with diuretics plus angiotensin-converting enzyme inhibitors [J].
Aronow, WS ;
Ahn, C ;
Kronzon, I .
AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 (02) :207-209
[7]   Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function.: Results of the Swedish Doppler-echocardiographic study (SWEDIC) [J].
Bergström, A ;
Andersson, B ;
Edner, M ;
Nylander, E ;
Persson, H ;
Dahlström, U .
EUROPEAN JOURNAL OF HEART FAILURE, 2004, 6 (04) :453-461
[8]   How strong is the evidence for use of beta-blockers as first-line therapy for hypertension? Systematic review and meta-analysis [J].
Bradley, Hazel A. ;
Wiysonge, Charles Shey ;
Volmink, Jimmy A. ;
Mayosi, Bongani M. ;
Opie, Lionel H. .
JOURNAL OF HYPERTENSION, 2006, 24 (11) :2131-2141
[9]   Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure [J].
Colucci, WS ;
Packer, M ;
Bristow, MR ;
Gilbert, EM ;
Cohn, JN ;
Fowler, MB ;
Krueger, SK ;
Hershberger, R ;
Uretsky, BF ;
Bowers, JA ;
SacknerBernstein, JD ;
Young, ST ;
Holcslaw, TL ;
Lukas, MA .
CIRCULATION, 1996, 94 (11) :2800-2806
[10]   Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial [J].
Dargie, HJ ;
Colucci, Y ;
Ford, I ;
Sendon, JLL ;
Remme, W ;
Sharpe, N ;
Blank, A ;
Holcslaw, TL .
LANCET, 2001, 357 (9266) :1385-1390